Similar articles

• Lesinurad/Allopurinol (Duzallo) for Gout-Associated Hyperuricemia.

  [No authors listed] [No authors listed] JAMA. 2018 Jan 9;319(2):188-189. doi: 10.1001/jama.2017.20189. JAMA. 2018. PMID: 29318274 No abstract available.
• Lesinurad: A Review in Hyperuricaemia of Gout.

  Deeks ED. Deeks ED. Drugs Aging. 2017 May;34(5):401-410. doi: 10.1007/s40266-017-0461-y. Drugs Aging. 2017. PMID: 28425024 Review.
• Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).

  Bardin T, Keenan RT, Khanna PP, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, So A. Bardin T, et al. Ann Rheum Dis. 2017 May;76(5):811-820. doi: 10.1136/annrheumdis-2016-209213. Epub 2016 Nov 7. Ann Rheum Dis. 2017. PMID: 27821644 Free PMC article. Clinical Trial.
• Approach to the treatment of hyperuricemia.

  Poon SH, Hall HA, Zimmermann B. Poon SH, et al. Med Health R I. 2009 Nov;92(11):359-62. Med Health R I. 2009. PMID: 19999894 Review. No abstract available.
• An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.

  Huang X, Du H, Gu J, Zhao D, Jiang L, Li X, Zuo X, Liu Y, Li Z, Li X, Zhu P, Li J, Zhang Z, Huang A, Zhang Y, Bao C. Huang X, et al. Int J Rheum Dis. 2014 Jul;17(6):679-86. doi: 10.1111/1756-185X.12266. Epub 2014 Jan 28. Int J Rheum Dis. 2014. PMID: 24467549 Clinical Trial.